ArticleDermatology and therapy2026
Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.
Tiago Torres et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.